Production (Stage)
Xilio Therapeutics, Inc.
XLO
$0.8838
-$0.0132-1.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 89.07M | 55.29M | 61.26M | 74.95M | 33.98M |
| Total Receivables | 2.00M | 2.00M | -- | -- | 30.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.13M | 2.94M | 2.05M | 3.06M | 5.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 93.20M | 60.23M | 63.31M | 78.01M | 69.19M |
|
|
|||||
| Total Current Assets | 93.20M | 60.23M | 63.31M | 78.01M | 69.19M |
| Net Property, Plant & Equipment | 8.73M | 9.06M | 9.57M | 10.00M | 10.54M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.79M | 1.78M | 1.78M | 1.86M | 2.88M |
| Total Assets | 103.72M | 71.08M | 74.66M | 89.87M | 82.61M |
|
|
|||||
| Total Accounts Payable | 2.28M | 2.57M | 972.00K | 1.26M | 746.00K |
| Total Accrued Expenses | 3.88M | 9.98M | 9.79M | 9.74M | 8.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.23M | 1.19M | 1.15M | 1.12M | 1.11M |
| Total Finance Division Other Current Liabilities | 40.25M | 13.52M | 26.11M | 26.52M | 21.73M |
| Total Other Current Liabilities | 40.25M | 13.52M | 26.11M | 26.52M | 21.73M |
| Total Current Liabilities | 47.64M | 27.26M | 38.02M | 38.64M | 31.58M |
|
|
|||||
| Total Current Liabilities | 47.64M | 27.26M | 38.02M | 38.64M | 31.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.64M | 6.95M | 7.26M | 7.57M | 7.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 38.74M | 19.26M | 8.40M | 10.25M | 17.40M |
| Total Liabilities | 93.02M | 53.48M | 53.68M | 56.46M | 56.84M |
|
|
|||||
| Common Stock & APIC | 407.72M | 401.35M | 391.63M | 390.06M | 368.48M |
| Retained Earnings | -397.02M | -383.75M | -370.66M | -356.64M | -342.72M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.70M | 17.60M | 20.97M | 33.42M | 25.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.70M | 17.60M | 20.97M | 33.42M | 25.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.70M | 17.60M | 20.97M | 33.42M | 25.77M |
|
|
|||||